Publications by authors named "Richard P Shank"

Claim this Profile
M
Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.
Richard P Shank, Bruce E Maryanoff

CNS Neurosci Ther· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbonic anhydrase inhibition. Insight into the characteristics of zonisamide, topiramate, and the sulfamide cognate of topiramate.
Richard P Shank, Virginia L Smith-Swintosky, Bruce E Maryanoff

J Enzyme Inhib Med Chem· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examination of two independent kinetic assays for determining the inhibition of carbonic anhydrases I and II: structure-activity comparison of sulfamates and sulfamides.
Richard P Shank, David F McComsey, Virginia L Smith-Swintosky, Bruce E Maryanoff

Chem Biol Drug Des· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of carbonic anhydrase-II by sulfamate and sulfamide groups: an investigation involving direct thermodynamic binding measurements.
Alexandra L Klinger, David F McComsey, Virginia Smith-Swintosky, Richard P Shank, Bruce E Maryanoff

J Med Chem· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of sulfamate and sulfamide groups for the inhibition of carbonic anhydrase-II by using topiramate as a structural platform.
Bruce E Maryanoff, David F McComsey, Michael J Costanzo, Coralie Hochman, Virginia Smith-Swintosky, Richard P Shank

J Med Chem· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase.
Richard P Shank, Dennis R Doose, Anthony J Streeter, Meir Bialer

Epilepsy Res· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topiramate monotherapy in epilepsy and migraine prevention.
Stephen D Silberstein, Elinor Ben-Menachem, Richard P Shank, Frank Wiegand

Clin Ther· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolytic.
Barry Dubinsky, Anil H Vaidya, Daniel I Rosenthal, Coralie Hochman, Jeffrey J Crooke, Richard P Shank

J Pharmacol Exp Ther· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis